These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28127880)

  • 1. SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications.
    Anjo SI; Santa C; Manadas B
    Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 28127880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.
    Narasimhan M; Kannan S; Chawade A; Bhattacharjee A; Govekar R
    J Transl Med; 2019 May; 17(1):184. PubMed ID: 31151397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reference library of peripheral blood mononuclear cells for SWATH-MS analysis.
    Silva C; Santa C; Anjo SI; Manadas B
    Proteomics Clin Appl; 2016 Jul; 10(7):760-4. PubMed ID: 27188786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometric protein maps for biomarker discovery and clinical research.
    Liu Y; Hüttenhain R; Collins B; Aebersold R
    Expert Rev Mol Diagn; 2013 Nov; 13(8):811-25. PubMed ID: 24138574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.
    Sajic T; Liu Y; Aebersold R
    Proteomics Clin Appl; 2015 Apr; 9(3-4):307-21. PubMed ID: 25504613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Set of Conserved Eukaryotic Internal Retention Time Standards for Data-independent Acquisition Mass Spectrometry.
    Parker SJ; Rost H; Rosenberger G; Collins BC; Malmström L; Amodei D; Venkatraman V; Raedschelders K; Van Eyk JE; Aebersold R
    Mol Cell Proteomics; 2015 Oct; 14(10):2800-13. PubMed ID: 26199342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based proteomic quest for diabetes biomarkers.
    Shao S; Guo T; Aebersold R
    Biochim Biophys Acta; 2015 Jun; 1854(6):519-27. PubMed ID: 25556002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human follicular fluid proteomic and peptidomic composition quantitative studies by SWATH-MS methodology. Applicability of high pH RP-HPLC fractionation.
    Lewandowska AE; Macur K; Czaplewska P; Liss J; Łukaszuk K; Ołdziej S
    J Proteomics; 2019 Jan; 191():131-142. PubMed ID: 29530678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in quantitative proteomics - an update.
    Li H; Han J; Pan J; Liu T; Parker CE; Borchers CH
    J Mass Spectrom; 2017 May; 52(5):319-341. PubMed ID: 28418607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.
    Collins BC; Hunter CL; Liu Y; Schilling B; Rosenberger G; Bader SL; Chan DW; Gibson BW; Gingras AC; Held JM; Hirayama-Kurogi M; Hou G; Krisp C; Larsen B; Lin L; Liu S; Molloy MP; Moritz RL; Ohtsuki S; Schlapbach R; Selevsek N; Thomas SN; Tzeng SC; Zhang H; Aebersold R
    Nat Commun; 2017 Aug; 8(1):291. PubMed ID: 28827567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated SWATH Data Analysis Using Targeted Extraction of Ion Chromatograms.
    Röst HL; Aebersold R; Schubert OT
    Methods Mol Biol; 2017; 1550():289-307. PubMed ID: 28188537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Analysis of Human Neural Stem Cell Differentiation by SWATH-MS.
    Tyleckova J; Cervenka J; Poliakh I; Novak J; Kepkova KV; Skalnikova HK; Vodicka P
    Methods Mol Biol; 2022; 2520():335-360. PubMed ID: 35579839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing translational research and precision medicine with targeted proteomics.
    Uzozie AC; Aebersold R
    J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the SWATH-MS-workflow for label-free proteomics.
    Simbürger JMB; Dettmer K; Oefner PJ; Reinders J
    J Proteomics; 2016 Aug; 145():137-140. PubMed ID: 27107778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS.
    Liu Y; Hüttenhain R; Surinova S; Gillet LC; Mouritsen J; Brunner R; Navarro P; Aebersold R
    Proteomics; 2013 Apr; 13(8):1247-56. PubMed ID: 23322582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.
    Luo Y; Mok TS; Lin X; Zhang W; Cui Y; Guo J; Chen X; Zhang T; Wang T
    Sci Rep; 2017 Jan; 7():41191. PubMed ID: 28117408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Building Mass Spectrometry Spectral Libraries of Human Cancer Cell Lines].
    Faktor J; Bouchal P
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):54-58. PubMed ID: 27846721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating SWATH-MS proteomics and transcriptome analysis to preliminarily identify three DEGs as biomarkers for proliferative diabetic retinopathy.
    Wu H; Wang D; Zheng Q; Xu Z
    Proteomics Clin Appl; 2022 Jan; 16(1):e2100016. PubMed ID: 34528762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing SWATH-MS as a tool for proteome level quantification in a nonmodel fish.
    Monroe AA; Zhang H; Schunter C; Ravasi T
    Mol Ecol Resour; 2020 Nov; 20(6):1647-1657. PubMed ID: 32687632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.